Edap Tms (EDAP) Competitors

AxoGen (NASDAQ:AXGN) and Edap Tms (NASDAQ:EDAP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Does the media prefer AXGN or EDAP?

In the previous week, Edap Tms had 4 more articles in the media than AxoGen. MarketBeat recorded 8 mentions for Edap Tms and 4 mentions for AxoGen. Edap Tms' average media sentiment score of 1.23 beat AxoGen's score of -0.01 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edap Tms	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger earnings & valuation, AXGN or EDAP?

AxoGen has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than AxoGen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$159.01M	1.66	-$21.72M	-$0.50	-12.08
Edap Tms	$65.42M	3.81	-$22.92M	-$0.54	-12.43

Does the MarketBeat Community believe in AXGN or EDAP?

AxoGen received 100 more outperform votes than Edap Tms when rated by MarketBeat users. Likewise, 72.48% of users gave AxoGen an outperform vote while only 62.84% of users gave Edap Tms an outperform vote.

Company	Underperform	Outperform
AxoGen	Outperform Votes 445 72.48%	Underperform Votes 169 27.52%
Edap Tms	Outperform Votes 345 62.84%	Underperform Votes 204 37.16%

Do institutionals & insiders have more ownership in AXGN or EDAP?

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 62.7% of Edap Tms shares are owned by institutional investors. 7.0% of AxoGen shares are owned by company insiders. Comparatively, 0.2% of Edap Tms shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has more volatility & risk, AXGN or EDAP?

AxoGen has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, Edap Tms has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500.

Do analysts rate AXGN or EDAP?

AxoGen currently has a consensus target price of $10.67, suggesting a potential upside of 76.60%. Edap Tms has a consensus target price of $14.00, suggesting a potential upside of 108.64%. Given AxoGen's higher possible upside, analysts plainly believe Edap Tms is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Edap Tms	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is AXGN or EDAP more profitable?

AxoGen has a net margin of -12.99% compared to AxoGen's net margin of -30.12%. Edap Tms' return on equity of -22.18% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-12.99%	-22.18%	-11.06%
Edap Tms	-30.12%	-30.52%	-19.64%

Summary

AxoGen beats Edap Tms on 14 of the 17 factors compared between the two stocks.